Interesting Stocks: Vodafone Group Plc (NASDAQ:VOD), Tesla Motors Inc (NASDAQ:TSLA), Pfizer (NYSE:PFE), Corium International (NASDAQ:CORI)

Posted by on Apr 18, 2016

Constellium N.V (NYSE:CSTM) shares fell -1.27% in last trading session and ended the day at $5.43. CSTM Gross Margin is 8.40% and its has a return on assets of -13.80%. Constellium N.V (NYSE:CSTM) quarterly performance is -21.98%.

On 7 April, Constellium N.V (NYSE:CSTM) announced the opening of the Constellium University Technology Center (UTC) at Brunel University London today. The Constellium University Technology Center is, according to the firm, “a dedicated center of excellence for the design, development and prototyping of aluminium alloys and automotive structural components.”

On 15 April, Vodafone Group Plc (ADR) (NASDAQ:VOD) shares advanced 1.48% and was closed at $32.83. VOD EPS growth in last 5 year was -6.50%. Vodafone Group Plc (ADR) (NASDAQ:VOD) year to date (YTD) performance is 1.77%.

Vodafone Group Plc (ADR) (NASDAQ:VOD) claims it is leading the telecoms industry with a new 30 day network guarantee for customers.

Tesla Motors Inc (NASDAQ:TSLA) shares advanced 1.05% in last trading session and ended the day at $254.51. TSLA Gross Margin is 22.80% and its has a return on assets of -12.60%. Tesla Motors Inc (NASDAQ:TSLA) quarterly performance is 23.44%.

Tesla Motors Inc (NASDAQ:TSLA) is recalling 2,700 Model X SUVs after the automaker’s own tests showed the third-row seats could snap forward in a crash.

Pfizer Inc. (NYSE:PFE) caters to the Healthcare space. It has a net profit margin of 19.10%. On the last day of trading company shares ended up at $32.50. Pfizer Inc. (NYSE:PFE) distance from 50-day simple moving average (SMA50) is 7.76%.

Pfizer Inc. (NYSE:PFE) said that, it is aiming to have a sensor-enabled remote patient monitoring system in place by 2019. The Big Pharma has teamed up with IBM ($IBM) for the project, which will construct a sensor-laden connected house to test the concept ahead of its planned use in a Phase III Parkinson’s disease trial in 2019.

Corium International, Inc. (NASDAQ:CORI) caters to the Healthcare space. Its weekly performance is 6.76%. On the last day of trading company shares ended up at $4.58. Corium International, Inc. (NASDAQ:CORI) distance from 50-day simple moving average (SMA50) is 4.73%.

Corium International Inc (NASDAQ:CORI) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Monday, Market Beat reports.

Leave a Reply

Your email address will not be published. Required fields are marked *